paper-with-me

홈 › Papers

Predicting brain tumour enhancement from non-contrast MR imaging with artificial intelligence: a multi-cohort retrospective diagnostic accuracy study

2025-08-19 · James K Ruffle, Samia Mohinta, Guilherme Pombo, Asthik Biswas, Alan Campbell, Indran Davagnanam, David Doig, Ahmed Hammam, Harpreet Hyare, Farrah Jabeen, Emma Lim, Dermot Mallon, Stephanie Owen, Sophie Wilkinson, Sebastian Brandner, Parashkev Nachev arxiv

Brain tumour MRI typically requires both pre- and post-contrast imaging, but gadolinium is not always desirable (frequent follow-up, renal impairment, allergy, paediatric patients). We developed and validated a deep learning model to predict tumour contrast enhancement from non-contrast MRI alone. We assembled 11,089 brain MRI studies (2006-2024) from 10 datasets across four countries and three continents, spanning adult and paediatric populations with glioma, meningioma, metastases, and post-resection appearances. Three architectures were trained to detect and segment enhancing tumour from T1w, T2w and FLAIR alone. Performance was assessed in a 1,109-study held-out test set (primary endpoint: patient-level enhancement detection; secondary: voxel-level Dice). Eleven expert radiologists attempted the same task on a 564-case subset (100 cases each), blinded to history, prior imaging, and referral. The best model, nnU-Net, achieved 83.0% balanced accuracy (95% CI 79.1-87.2; sensitivity 91.5%, specificity 74.4%) for detection, with R2 = 0.859 for enhancement volume. Of enhancing cases, 76.8% reached Dice >= 0.3, 67.5% >= 0.5, and 50.2% >= 0.7. Under blinded conditions, radiologists' majority vote was lower (71.7% balanced accuracy; sensitivity 77.6%, specificity 65.8%). The proportion reaching Dice >= 0.3 varied by pathology (meningioma 93%, presurgical glioma 76%, metastases 74%, postoperative glioma 74%) and was lowest for paediatric cases (45%). Deep learning can identify contrast-enhancing brain tumours from non-contrast MRI. These models show promise as a triage or decision-support adjunct, such as in flagging studies likely to enhance so that contrast can be added to a non-contrast protocol, and may reduce gadolinium dependence in neuro-oncology imaging. Future work should optimise these models with radiologists.

📄 PDF Abstract BibTeX arXiv:2508.16650

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Brain tumour segmentation with incomplete imaging data

2022-06-13 · James K Ruffle, Samia Mohinta, Robert J Gray, Harpreet Hyare 외

The complex heterogeneity of brain tumours is increasingly recognized to demand data of magnitudes and richness only fully-inclusive, large-scale collections drawn from routine clinical care could plausibly offer. This i…

Segmentation

Combining multi-site Magnetic Resonance Imaging with machine learning predicts survival in paediatric brain tumours

2020-04-21

Background Brain tumours represent the highest cause of mortality in the paediatric oncological population. Diagnosis is commonly performed with magnetic resonance imaging and spectroscopy. Survival biomarkers are challe…

Survival Analysis

Frequency selection for the diagnostic characterization of human brain tumours

2025-03-11 · Carlos Arizmendi, Alfredo Vellido, Enrique Romero

The diagnosis of brain tumours is an extremely sensitive and complex clinical task that must rely upon information gathered through non-invasive techniques. One such technique is magnetic resonance, in the modalities of …

Diagnostic

Brain MR Image Synthesis with 3D Multi-Contrast Self-Attention GAN

2026-03-31 · Zaid A. Abod, Furqan Aziz arxiv

Complete and high-quality multi-modal Magnetic Resonance Imaging (MRI) is essential for accurate neuro-oncological assessment, as each contrast provides complementary anatomical and pathological information. However, acq…

AA-ViT: Anatomically Aware Vision Transformer with Structural and Frequency Guidance for Contrast Enhanced Brain MRI Synthesis

2026-07-08 · Talha Meraj, Tom Flannery, Charlie Cummins, Matt Townend 외 arxiv

Accurate tumour localization and diagnosis is a critical component of clinical care for brain cancers. Magnetic Resonance Imaging (MRI) is the most commonly used imaging modality due to its superior soft-tissue contrast.…